BWAY
Price:
$9.431
Market Cap:
$177.43M
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem,...[Read more]
Industry
Medical - Devices
IPO Date
2019-04-17
Stock Exchange
NASDAQ
Ticker
BWAY
According to BrainsWay Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 117.89. This represents a change of -53.30% compared to the average of 252.45 of the last 4 quarters.
The mean historical PE Ratio of BrainsWay Ltd. over the last ten years is -29.97. The current 117.89 PE Ratio has changed -39437.63% with respect to the historical average. Over the past ten years (40 quarters), BWAY's PE Ratio was at its highest in in the December 2023 quarter at 418.93. The PE Ratio was at its lowest in in the September 2023 quarter at -145.78.
Average
-29.97
Median
-27.04
Minimum
-65.56
Maximum
-5.69
Discovering the peaks and valleys of BrainsWay Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 349.54%
Maximum Annual PE Ratio = -5.69
Minimum Annual Increase = -84.66%
Minimum Annual PE Ratio = -65.56
Year | PE Ratio | Change |
---|---|---|
2023 | -25.60 | 349.54% |
2022 | -5.69 | -84.66% |
2021 | -37.12 | 18.16% |
2020 | -31.42 | 62.29% |
2019 | -19.36 | -32.03% |
2018 | -28.48 | 22.67% |
2017 | -23.22 | -64.58% |
2016 | -65.56 | 67.05% |
2015 | -39.25 | 63.56% |
2014 | -23.99 | 19.76% |
The current PE Ratio of BrainsWay Ltd. (BWAY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-22.80
5-year avg
-23.84
10-year avg
-29.97
BrainsWay Ltd.’s PE Ratio is greater than Medigus Ltd. (-0.16), greater than Delcath Systems, Inc. (-9.47), greater than Heska Corporation (-67.36), greater than Paragon 28, Inc. (-14.08), greater than QHSLab, Inc. (-39.71), greater than Vapotherm, Inc. (7.12), greater than Venus Concept Inc. (-0.05), greater than Tactile Systems Technology, Inc. (27.08), greater than NeuroPace, Inc. (-11.85), greater than Electromed, Inc. (39.47), greater than OrthoPediatrics Corp. (-18.47), greater than Surmodics, Inc. (-48.77), greater than CVRx, Inc. (-4.99), greater than Orthofix Medical Inc. (-5.59), greater than Artivion, Inc. (-1402.54), greater than Aziyo Biologics, Inc. (-2.38), greater than Ainos, Inc. (-0.31), greater than LENSAR, Inc. (-6.08), greater than IRIDEX Corporation (-2.43),
Company | PE Ratio | Market cap |
---|---|---|
-0.16 | $4.47M | |
-9.47 | $359.39M | |
-67.36 | $1.31B | |
-14.08 | $859.39M | |
-39.71 | $2.34M | |
7.12 | $13.55M | |
-0.05 | $2.53M | |
27.08 | $418.51M | |
-11.85 | $337.43M | |
39.47 | $252.13M | |
-18.47 | $548.97M | |
-48.77 | $567.08M | |
-4.99 | $310.82M | |
-5.59 | $660.72M | |
-1402.54 | $1.19B | |
-2.38 | $24.21M | |
-0.31 | $6.15M | |
-6.08 | $101.16M | |
-2.43 | $26.91M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BrainsWay Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BrainsWay Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is BrainsWay Ltd.'s PE Ratio?
How is the PE Ratio calculated for BrainsWay Ltd. (BWAY)?
What is the highest PE Ratio for BrainsWay Ltd. (BWAY)?
What is the 3-year average PE Ratio for BrainsWay Ltd. (BWAY)?
What is the 5-year average PE Ratio for BrainsWay Ltd. (BWAY)?
How does the current PE Ratio for BrainsWay Ltd. (BWAY) compare to its historical average?